CRT 2024
Coronary
Cardiogenic Shock [Non-CME]
Srihari S. Naidu, MD, FSCAI
Director, Cath Labs and HCM Program
Westchester Medical Center
Valhalla, New York, United States
No relationships to disclose
Michele D. Voeltz, MD, FACC, FSCAI
Attending Physician
Northside Cardiovascular Institute
Buford, Georgia, United States
Disclosure(s): Medtronic, Pulnovo, Abiomed, Amgen, Boehringer Ingelheim: Advisor (Ongoing)
William T. Abraham, MD
Professor of Medicine
The Ohio State University
Columbus, Ohio, United States
Disclosure information not submitted.
Donald E. Cutlip, MD, FACC
Vice Chair, Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure information not submitted.
Nihar Desai, MD, MPH
Associate Professor of Medicine, Vice Chief, Cardiovascular Medicine
Yale School of Medicine
Shelton, Connecticut, United States
Disclosure information not submitted.
Mahesh Deshpande, MS, MBA
Global Sr. Drug Eluting Strategy Product Manager
Boston Scientific
Maple Grove, Minnesota, United States
Disclosure information not submitted.
Maya Guglin, MD
Director of Heart Failure/Transplant/MCS
Indiana University
Indianapolis, Indiana, United States
Disclosure information not submitted.
Tarek Helmy, MD, FACC, MSCAI
Chief of Cardiology and Director of Cardiac Cath Lab
Ochsner LSU
Shreveport, Louisiana, United States
Disclosure information not submitted.
Mitchell Krucoff, MD, FACC
Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States
Disclosure information not submitted.
Duane Pinto, MD, MPH, FSCAI
Chief Medical Officer
JenaValve
Boston, Massachusetts, United States
No relationships to disclose
Charles A. Simonton, MD, FACC, FSCAI
EVP Chief Medical Officer
Abiomed Inc
Charlotte, North Carolina, United States
Disclosure information not submitted.
Gregg W. Stone, MD, FACC, MSCAI
Physician
Mount Sinai
New York, New York, United States
Disclosure information not submitted.